Completed NA INTERVENTIONAL 2-arm NCT00651625

Reciprocating Medical Devices - a Study of a New Safety Device (RPD)

Randomized Controlled Trial of the Reciprocating Procedure Device Versus the Conventional Syringe in Syringe-and-Needle Procedures

Sponsor: University of New Mexico

Conditions Cancer Osteoarthritis Rheumatoid Arthritis Thyroid Nodule Trauma

Interventions Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001 conventional syringe - BD Ref 309604

Updated 8 times since 2017 Last updated: Feb 2, 2016 Started: Nov 30, 2004 Primary completion: Jan 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cancer and Osteoarthritis, this trial is completed. The trial is conducted by University of New Mexico and has accumulated 8 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of New Mexico

Data source: University of New Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Albuquerque, United States